一本新的科學劇本

政府效率部（DOGE）最近宣布實施一種新方法來資助科學研究的方法，引發了科學界的激烈辯論。

The recent announcement by the Department of Government Efficiency (DOGE) to devise a new approach to funding scientific research has sparked a heated debate within the scientific community. As the DOGE's plans to introduce a new funding model that prioritizes cost-cutting and efficiency have come to light, the emphasis on cutting costs and optimizing efficiency may seem appealing at first glance. However, this focus disregards the fundamental principles and complexities of scientific research.

政府效率部（DOGE）最近宣布，設計一種新方法來資助科學研究，這引發了科學界的激烈辯論。由於總督介紹新的資金模型的計劃已經闡明了優先考慮成本和效率的優先級，因此乍看之下，強調削減成本和優化效率的重視似乎很有吸引力。但是，這個重點無視科學研究的基本原理和復雜性。

In this article, we will delve into the need for a new approach to funding scientific research, one that prioritizes investment in knowledge, lifesaving drugs, and technological capability over short-term budgetary concerns.

在本文中，我們將深入研究一種新方法來資助科學研究的方法，該方法優先考慮知識，救生藥物和技術能力，而不是短期預算關注的問題。

Investing in Scientific Research

投資科學研究

Scientific research should be viewed as a crucial investment in the future of humanity. It drives innovation, improves healthcare, and enhances our understanding of the world around us. However, the current funding model is flawed, leading to a lack of investment in knowledge and a prioritization of short-term gains over long-term benefits. While the DOGE's approach to cutting costs and optimizing efficiency may seem like a solution to this problem, it is a misguided one.

科學研究應被視為對人類未來的關鍵投資。它推動創新，改善醫療保健並增強我們對周圍世界的理解。但是，當前的資金模式存在缺陷，導致缺乏對知識的投資，並優先考慮長期收益而不是長期收益。儘管總督削減成本和優化效率的方法似乎是解決這個問題的解決方案，但這是一個誤導的問題。

Scientific research requires a long-term investment in knowledge and expertise, which cannot be achieved through short-term cost-cutting measures. To illustrate this point further, consider the example of Katalin Karikó, a Hungarian biochemist who developed the mRNA technology used in COVID-19 vaccines. Karikó's research was initially met with skepticism and rejection from the scientific community. Despite the setbacks and difficulties she encountered, Karikó persevered in her pursuit of this groundbreaking technology.

科學研究需要對知識和專業知識進行長期投資，這是無法通過短期削減成本措施來實現的。為了進一步說明這一點，請考慮匈牙利生物化學家KatalinKarikó的例子，他開發了Covid-19疫苗中使用的mRNA技術。 Karikó的研究最初受到科學界的懷疑和拒絕。儘管她遇到了挫折和困難，但Karikó仍然堅持​​追求這項開創性的技術。

After facing difficulties securing funding and encountering skepticism from her peers, Karikó was eventually able to continue her research and made significant contributions to the development of mRNA vaccines. These vaccines have played a lifesaving role in combating the COVID-19 pandemic, showcasing the importance of investing in knowledge and innovation over short-term budgetary concerns.

在面臨著確保資金並遇到同齡人懷疑的困難之後，卡里科最終能夠繼續她的研究，並為mRNA疫苗的開發做出了重大貢獻。這些疫苗在打擊共證於199大流行方面發揮了救生作用，展示了投資於短期預算關注的知識和創新的重要性。

Measuring Efficiency

測量效率

Measuring efficiency in scientific research is a challenging endeavor, and the DOGE's approach to cutting costs and optimizing efficiency is oversimplified. Scientific research is not a procurement process that can be easily measured by focusing on the bottom line. Instead, it should be viewed as an investment portfolio that requires a long-term view and an evaluation of the overall impact and return on investment.

衡量科學研究的效率是一項具有挑戰性的努力，而多奇的降低成本和優化效率的方法被過度簡化。科學研究不是一個可以通過關注底線來輕鬆衡量的採購過程。相反，應該將其視為一種投資組合，需要長期觀察並評估整體影響和投資回報率。

The DOGE's approach to measuring efficiency may lead to a lack of investment in knowledge and innovation, ultimately hindering the progress of scientific research. A more nuanced approach is needed, one that takes into account the returns on investment, including the development of lifesaving drugs, technological capability, and innovation.

總督測量效率的方法可能導致對知識和創新的投資缺乏投資，最終阻礙了科學研究的進步。需要一種更細微的方法，即考慮投資回報的回報，包括救生藥物的開發，技術能力和創新。

By adopting this approach and evaluating the impact of scientific research on society, we can ensure that it is funded in a way that prioritizes knowledge and innovation over short-term budgetary concerns. This shift in focus is essential for continuing to advance scientific progress and reaping the benefits of groundbreaking discoveries.

通過採用這種方法並評估科學研究對社會的影響，我們可以確保以優先考慮知識和創新優先於短期預算關注的方式來資助。這種重點轉變對於繼續提高科學進步並獲得開創性發現的好處至關重要。

Supporting Visionary Research

支持有遠見的研究

The importance of supporting visionary researchers like Katalin Karikó cannot be overstated. Their creativity and innovation are the driving forces behind groundbreaking discoveries and technological advancements. However, the DOGE's approach to cutting costs and optimizing efficiency may inadvertently stifle this creativity and innovation. A funding model that encourages innovation and risk-taking is needed, one that provides support for visionary researchers and their projects.

支持KatalinKarikó等有遠見的研究人員的重要性不能被誇大。他們的創造力和創新是開創性發現和技術進步背後的動力。但是，總督削減成本和優化效率的方法可能會無意中扼殺這種創造力和創新。需要一種鼓勵創新和冒險的資金模型，該模型為有遠見的研究人員及其項目提供了支持。

This support should not be limited to research that promises immediate practical applications or cost-cutting opportunities. Instead, it should encompass a broad range of scientific endeavors, including those that explore fundamental scientific questions or pursue highly speculative avenues of inquiry.

這種支持不僅限於有望立即實用應用或削減成本機會的研究。取而代之的是，它應該涵蓋廣泛的科學努力，包括那些探討基本科學問題或追求高度投機性探究途徑的努力。

The example of the National Institutes of Health (NIH) and the National Science Foundation (NSF) demonstrates the importance of supporting visionary research. These organizations provide funding for scientific research that is often considered high-risk and high-reward. By investing in these types of projects, we can drive innovation and progress in scientific research, ultimately leading to breakthroughs that benefit society as a whole.

美國國立衛生研究院（NIH）和國家科學基金會（NSF）的例子表明，支持有遠見的研究的重要性。這些組織為科學研究提供資金，通常被認為是高風險和高回報。通過投資這些類型的項目，我們可以推動科學研究的創新和進步，最終導致突破，從而使整個社會受益。

In contrast, the DOGE's approach to cutting costs and optimizing efficiency may lead to a prioritization of short-term gains over long-term benefits. This shift in focus could have devastating consequences for the future of scientific research and technological advancement. As we've seen with the COVID-19 pandemic, investing in knowledge and innovation pays off in unexpected and often lifesaving ways. We must not lose sight of this crucial fact as we strive to improve the efficiency and effectiveness of government programs.

相比之下，總督削減成本和優化效率的方法可能會導致短期收益優先考慮長期收益。這種重點轉變可能會對科學研究和技術進步的未來產生毀滅性的後果。正如我們在Covid-19的大流行中所看到的那樣，投資知識和創新以意想不到的且經常挽救生命的方式得到回報。當我們努力提高政府計劃的效率和有效性時，我們絕不能忽視這一關鍵事實。